Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Hepatitis C Treatment Snapshots: Daclatasvir
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Asia Pacific Situational Updates on Generic DAAs – June 2017
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
